Preclinical evaluation of cellular immune responses elicited by a polyvalent DNA prime/protein boost HIV-1 vaccine

Virology

Volumn 346, Issue 1, 2006, Pages 151-168

  Cristillo, Anthony D ^a   Wang, Shixia ^b   Caskey, Michael S ^a   Unangst, Tami ^a   Hocker, Lindsey ^a   He, Leilei ^a   Hudacik, Lauren ^a   Whitney, Stephen ^a   Keen, Tim ^a   Chou, Te Hui W ^b   Shen, Siyuan ^b   Joshi, Swati ^b   Kalyanaraman, Vaniambadi S ^a   Nair, Balachandran ^a   Markham, Phillip ^a   Lu, Shan ^b   Pal, Ranajit ^a  

^a ADVANCED BIOSCIENCE LABORATORIES INC   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

AIDS; Boost; Cellular immunity; CMI; HIV 1; Polyvalent; Prime; Vaccine

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAG PROTEIN; GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; PLASMID DNA; RECOMBINANT PROTEIN; RECOMBINANT VACCINE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG TOLERANCE; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RHESUS MONKEY; T LYMPHOCYTE; TH1 CELL;

AIDS VACCINES; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; GENE PRODUCTS, ENV; GENE PRODUCTS, GAG; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, CELLULAR; IMMUNIZATION; IMMUNIZATION SCHEDULE; IMMUNIZATION, SECONDARY; MACACA MULATTA; MICE; MICE, INBRED BALB C; TH1 CELLS; VACCINES, DNA;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA; MACACA MULATTA; PRIMATES;

EID: 32844462280     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2005.10.038     Document Type: Article

References (82)

1. R.R. Amara, F. Villinger, S.I. Staprans, J.D. Altman, D.C. Montefiori, N.L. Kozyr, Y. Xu, L.S. Wyatt, P.L. Earl, J.G. Herndon, H.M. McClure, B. Moss, and H.L. Robinson Different patterns of immune responses but similar control of a simian-human immunodeficiency virus 89.6P mucosal challenge by modified vaccinia virus Ankara (MVA) and DNA/MVA vaccines J. Virol. 76 15 2002 7625 7631
2. S.S. Balla-Jhagjhoorsingh, G. Koopman, P. Mooij, W. Koornstra, S. McCormack, J. Weber, G. Pantaleo, and J.L. Heeney Long-term persistence of HIV-1 vaccine-induced CD4+CD45RA-CD62L-CCR7-memory T-helper cells AIDS 18 6 2004 837 848
3. S.W. Barnett, S. Rajasekar, H. Legg, B. Doe, D.H. Fuller, J.R. Haynes, C.M. Walker, and K.S. Steimer Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit vaccine Vaccine 15 8 1997 869 873
4. D.H. Barouch, M.G. Pau, J.H. Custers, W. Koudstaal, S. Kostense, M.J. Havenga, D.M. Truitt, S.M. Sumida, M.G. Kishko, J.C. Arthur, B. Korioth-Schmitz, M.H. Newberg, D.A. Gorgone, M.A. Lifton, D.L. Panicali, G.J. Nabel, N.L. Letvin, and J. Goudsmit Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity J. Immunol. 172 10 2004 6290 6297
5. M.J. Bevan Helping the CD8 (+) T-cell response Nat. Rev., Immunol. 4 8 2004 595 602
6. R.E. Bontrop, and D.I. Watkins MHC polymorphism: AIDS susceptibility in non-human primates Trends Immunol. 26 4 2005 227 233
7. M.R. Caro, N. Ortega, A.J. Buendia, M.C. Gallego, L. Del Rio, F. Cuello, and J. Salinas Relationship between the immune response and protection conferred by new designed inactivated vaccines against ovine enzootic abortion in a mouse model Vaccine 21 23 2003 3126 3136
8. D.R. Casimiro, A. Tang, L. Chen, T.M. Fu, R.K. Evans, M.E. Davies, D.C. Freed, W. Hurni, J.M. Aste-Amezaga, L. Guan, R. Long, L. Huang, V. Harris, D.K. Nawrocki, H. Mach, R.D. Troutman, L.A. Isopi, K.K. Murthy, K. Rice, K.A. Wilson, D.B. Volkin, E.A. Emini, and J.W. Shiver Vaccine-induced immunity in baboons by using DNA and replication-incompetent adenovirus type 5 vectors expressing a human immunodeficiency virus type 1 gag gene J. Virol. 77 13 2003 7663 7668
9. M.J. Caulfield, S. Wang, J.G. Smith, T.W. Tobery, X. Liu, M.E. Davies, D.R. Casimiro, T.M. Fu, A. Simon, R.K. Evans, E.A. Emini, and J. Shiver Sustained peptide-specific gamma interferon T-cell response in rhesus macaques immunized with human immunodeficiency virus gag DNA vaccines J. Virol. 76 19 2002 10038 10043
10. S.L. Constant, K.S. Lee, and K. Bottomly Site of antigen delivery can influence T cell priming: pulmonary environment promotes preferential Th2-type differentiation Eur. J. Immunol. 30 3 2000 840 847
11. D.H. Cribbs, A. Ghochikyan, V. Vasilevko, M. Tran, I. Petrushina, N. Sadzikava, D. Babikyan, P. Kesslak, T. Kieber-Emmons, C.W. Cotman, and M.G. Agadjanyan Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid Int. Immunol. 15 4 2003 505 514
12. C.J. Dale, A. Zhao, S.L. Jones, D.B. Boyle, I.A. Ramshaw, and S.J. Kent Induction of HIV-1-specific T-helper responses and type 1 cytokine secretion following therapeutic vaccination of macaques with a recombinant fowlpoxvirus co-expressing interferon-gamma J. Med. Primatol. 29 3-4 2000 240 247
13. L.M. Daly, P.A. Johnson, G. Donnelly, C. Nicolson, J. Robertson, and K.H. Mills Innate IL-10 promotes the induction of Th2 responses with plasmid DNA expressing HIV gp120 Vaccine 23 7 2005 963 974
14. P.L. Earl, L.S. Wyatt, D.C. Montefiori, M. Bilska, R. Woodward, P.D. Markham, J.D. Malley, T.U. Vogel, T.M. Allen, D.I. Watkins, N. Miller, and B. Moss Comparison of vaccine strategies using recombinant env-gag-pol MVA with or without an oligomeric Env protein boost in the SHIV rhesus macaque model Virology 294 2 2002 270 281
15. M.J. Estcourt, A.J. McMichael, and T. Hanke DNA vaccines against human immunodeficiency virus type 1 Immunol. Rev. 199 2004 144 155
16. T.G. Evans, M.J. McElrath, T. Matthews, D. Montefiori, K. Weinhold, M. Wolff, M.C. Keefer, E.G. Kallas, L. Corey, G.J. Gorse, R. Belshe, B.S. Graham, P.W. Spearman, D. Schwartz, M.J. Mulligan, P. Goepfert, P. Fast, P. Berman, M. Powell, and D. Francis QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immunization in humans Vaccine 19 15-16 2001 2080 2091
17. G. Fatkenheuer, A. Theisen, J. Rockstroh, T. Grabow, C. Wicke, K. Becker, U. Wieland, H. Pfister, M. Reiser, P. Hegener, C. Franzen, A. Schwenk, and B. Salzberger Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients AIDS 11 14 1997 F113 F116
18. A.S. Fauci, G. Pantaleo, S. Stanley, and D. Weissman Immunopathogenic mechanisms of HIV infection Ann. Intern. Med. 124 7 1996 654 663
19. G. Franchini, S. Gurunathan, L. Baglyos, S. Plotkin, and J. Tartaglia Poxvirus-based vaccine candidates for HIV: two decades of experience with special emphasis on canarypox vectors Expert Rev. Vaccines 3 Suppl. 4 2004 S75 S88
20. M.M. Gherardi, E. Perez-Jimenez, J.L. Najera, and M. Esteban Induction of HIV immunity in the genital tract after intranasal delivery of a MVA vector: enhanced immunogenicity after DNA prime-modified vaccinia virus Ankara boost immunization schedule J. Immunol. 172 10 2004 6209 6220
21. R.A. Gruters, C.A. van Baalen, and A.D. Osterhaus The advantage of early recognition of HIV-infected cells by cytotoxic T-lymphocytes Vaccine 20 15 2002 2011 2015
22. K. Haglund, I. Leiner, K. Kerksiek, L. Buonocore, E. Pamer, and J.K. Rose Robust recall and long-term memory T-cell responses induced by prime-boost regimens with heterologous live viral vectors expressing human immunodeficiency virus type 1 Gag and Env proteins J. Virol. 76 15 2002 7506 7517
23. G.E. Hancock, D.J. Speelman, P.J. Frenchick, M.M. Mineo-Kuhn, R.B. Baggs, and D.J. Hahn Formulation of the purified fusion protein of respiratory syncytial virus with the saponin QS-21 induces protective immune responses in Balb/c mice that are similar to those generated by experimental infection Vaccine 13 4 1995 391 400
24. T. Hanke, A.J. McMichael, M. Mwau, E.G. Wee, I. Ceberej, S. Patel, J. Sutton, M. Tomlinson, and R.V. Samuel Development of a DNA-MVA/HIVA vaccine for Kenya Vaccine 20 15 2002 1995 1998
25. T. Hanke, C. Barnfield, E.G. Wee, L. Agren, R.V. Samuel, N. Larke, and P. Liljestrom Construction and immunogenicity in a prime-boost regimen of a Semliki Forest virus-vectored experimental HIV clade A vaccine J. Gen. Virol. 84 Pt. 2 2003 361 368
26. Z. Hel, J. Nacsa, W.P. Tsai, A. Thornton, L. Giuliani, J. Tartaglia, and G. Franchini Equivalent immunogenicity of the highly attenuated poxvirus-based ALVAC-SIV and NYVAC-SIV vaccine candidates in SIVmac251-infected macaques Virology 304 1 2002 125 134
27. H. Horton, T.U. Vogel, D.K. Carter, K. Vielhuber, D.H. Fuller, T. Shipley, J.T. Fuller, K.J. Kunstman, G. Sutter, D.C. Montefiori, V. Erfle, R.C. Desrosiers, N. Wilson, L.J. Picker, S.M. Wolinsky, C. Wang, D.B. Allison, and D.I. Watkins Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression following challenge with pathogenic SIVmac239 J. Virol. 76 14 2002 7187 7202
28. P. Klenerman, R.E. Phillips, C.R. Rinaldo, L.M. Wahl, G. Ogg, R.M. May, A.J. McMichael, and M.A. Nowak Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection Proc. Natl. Acad. Sci. U.S.A. 93 26 1996 15323 15328
29. W.P. Kong, Y. Huang, Z.Y. Yang, B.K. Chakrabarti, Z. Moodie, and G.J. Nabel Immunogenicity of multiple gene and clade human immunodeficiency virus type 1 DNA vaccines J. Virol. 77 23 2003 12764 12772
30. F. Lemiale, D. Brand, S. Lebigot, B. Verrier, L. Buzelay, S. Brunet, and F. Barin Immunogenicity of recombinant envelope glycoproteins derived from T-cell line-adapted isolates or primary HIV isolates: a comparative study using multivalent vaccine approaches J. Acquired Immune Defic. Syndr. 26 5 2001 413 422
31. N.L. Letvin, and B.D. Walker Immunopathogenesis and immunotherapy in AIDS virus infections Nat. Med. 9 7 2003 861 866
32. N.L. Letvin, D.C. Montefiori, Y. Yasutomi, H.C. Perry, M.-E. Davies, C. Lekutis, M. Alroy, D.C. Freed, C.I. Lord, L.K. Handt, M.A. Lius, and J.W. Shiver Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein immunization Proc. Natl. Acad. Sci. U.S.A. 94 1997 9378 9383
33. N.L. Letvin, Y. Huang, B.K. Chakrabarti, L. Xu, M.S. Seaman, K. Beaudry, B. Korioth-Schmitz, F. Yu, D. Rohne, K.L. Martin, A. Miura, W.P. Kong, Z.Y. Yang, R.S. Gelman, O.G. Golubeva, D.C. Montefiori, J.R. Mascola, and G.J. Nabel Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys J. Virol. 78 14 2004 7490 7497
34. M. Lichterfeld, D.E. Kaufmann, X.G. Yu, S.K. Mui, M.M. Addo, M.N. Johnston, D. Cohen, G.K. Robbins, E. Pae, G. Alter, A. Wurcel, D. Stone, E.S. Rosenberg, B.D. Walker, and M. Altfeld Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells J. Exp. Med. 200 6 2004 701 712
35. L. Liu, A. Chahroudi, G. Silvestri, M.E. Wernett, W.J. Kaiser, J.T. Safrit, A. Komoriya, J.D. Altman, B.Z. Packard, and M.B. Feinberg Visualization and quantification of T cell-mediated cytotoxicity using cell-permeable fluorogenic caspase substrates Nat. Med. 8 2 2002 185 189
36. F. Liu, I. Mboudjeka, S. Shen, T.H. Chou, S. Wang, T.M. Ross, and S. Lu Independent but not synergistic enhancement to the immunogenicity of DNA vaccine expressing HIV-1 gp120 glycoprotein by codon optimization and C3d fusion in a mouse model Vaccine 22 13-14 2004 1764 1772
37. L. Liu, B.Z. Packard, M.J. Brown, A. Komoriya, and M.B. Feinberg Assessment of lymphocyte-mediated cytotoxicity using flow cytometry Methods Mol. Biol. 263 2004 125 140
38. J.T. Loffredo, J. Sidney, C. Wojewoda, E. Dodds, M.R. Reynolds, G. Napoe, B.R. Mothe, D.H. O'Connor, N.A. Wilson, D.I. Watkins, and A. Sette Identification of seventeen new simian immunodeficiency virus-derived CD8+ T cell epitopes restricted by the high frequency molecule, Mamu-A*02, and potential escape from CTL recognition J. Immunol. 173 8 2004 5064 5076
39. S. Lu, S. Manning, and J. Arthos Antigen engineering in DNA immunization W. Lowrie Method in Molecular Medicine, DNA Vaccines: Methods and Protocols vol. 29 1999 Humana Press Inc. Totowa, NJ 355 374
40. B. Makitalo, P. Lundholm, J. Hinkula, C. Nilsson, K. Karlen, A. Morner, G. Sutter, V. Erfle, J.L. Heeney, B. Wahren, G. Biberfeld, and R. Thorstensson Enhanced cellular immunity and systemic control of SHIV infection by combined parenteral and mucosal administration of a DNA prime MVA boost vaccine regimen J. Gen. Virol. 85 Pt. 8 2004 2407 2419
41. N. Malkevitch, D. Rohne, J. Pinczewski, K. Aldrich, V.S. Kalyanaraman, N.L. Letvin, and M. Robert-Guroff Evaluation of combination DNA/replication- competent Ad-SIV recombinant immunization regimens in rhesus macaques AIDS Res. Hum. Retrovir. 20 2 2004 235 244
42. A. Mocroft, B. Ledergerber, C. Katlama, O. Kirk, P. Reiss, A. d'Arminio Monforte, B. Knysz, M. Dietrich, A.N. Phillips, and J.D. Lundgren Decline in the AIDS and death rates in the EuroSIDA study: an observational study Lancet 362 9377 2003 22 29
43. A. Mocroft, L. Ruiz, P. Reiss, B. Ledergerber, C. Katlama, A. Lazzarin, F.D. Goebel, A.N. Phillips, B. Clotet, and J.D. Lundgren Virological rebound after suppression on highly active antiretroviral therapy AIDS 17 12 2003 1741 1751
44. A. Moore, L. McCarthy, and K.H. Mills The adjuvant combination monophosphoryl lipid A and QS21 switches T cell responses induced with a soluble recombinant HIV protein from Th2 to Th1 Vaccine 17 20-21 1999 2517 2527
45. M.J. Newman Heterologous prime-boost vaccination strategies for HIV-1: augmenting cellular immune responses Curr. Opin. Invest. Drugs 3 3 2002 374 378
46. M.J. Newman, J.Y. Wu, R.T. Coughlin, C.I. Murphy, J.R. Seals, M.S. Wyand, and C.R. Kensil Immunogenicity and toxicity testing of an experimental HIV-1 vaccine in nonhuman primates AIDS Res. Hum. Retrovir. 8 8 1992 1413 1418
47. D.H. O'Connor, B.R. Mothe, J.T. Weinfurter, S. Fuenger, W.M. Rehrauer, P. Jing, R.R. Rudersdorf, M.E. Liebl, K. Krebs, J. Vasquez, E. Dodds, J. Loffredo, S. Martin, A.B. McDermott, T.M. Allen, C. Wang, G.G. Doxiadis, D.C. Montefiori, A. Hughes, D.R. Burton, D.B. Allison, S.M. Wolinsky, R. Bontrop, L.J. Picker, and D.I. Watkins Major histocompatibility complex class I alleles associated with slow simian immunodeficiency virus disease progression bind epitopes recognized by dominant acute-phase cytotoxic-T-lymphocyte responses J. Virol. 77 16 2003 9029 9040
48. O.J. Ophorst, S. Kostense, J. Goudsmit, R.L. De Swart, S. Verhaagh, A. Zakhartchouk, M. Van Meijer, M. Sprangers, G. Van Amerongen, S. Yuksel, A.D. Osterhaus, and M.J. Havenga An adenoviral type 5 vector carrying a type 35 fiber as a vaccine vehicle: DC targeting, cross neutralization, and immunogenicity Vaccine 22 23-24 2004 3035 3044
49. M. Otero, S.A. Calarota, B. Felber, D. Laddy, G. Pavlakis, J.D. Boyer, and D.B. Weiner Resiquimod is a modest adjuvant for HIV-1 gag-based genetic immunization in a mouse model Vaccine 22 13-14 2004 1782 1790
50. R. Pal, D. Venzon, N.L. Letvin, S. Santra, D.C. Montefiori, N.R. Miller, E. Tryniszewska, M.G. Lewis, T.C. VanCott, V. Hirsch, R. Woodward, A. Gibson, M. Grace, E. Dobratz, P.D. Markham, Z. Hel, J. Nacsa, M. Klein, J. Tartaglia, and G. Franchini ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency J. Virol. 76 1 2002 292 302
51. R. Pal, S. Wang, V.S. Kalyanaraman, B.C. Nair, S. Whitney, T. Keen, L. Hocker, L. Hudacik, N. Rose, A. Cristillo, I. Mboudjeka, S. Shen, T.H. Wu-Chou, D. Montefiori, J. Mascola, S. Lu, and P. Markham Polyvalent DNA prime and envelope protein boost HIV-1 vaccine elicits humoral and cellular responses and controls plasma viremia in rhesus macaques following rectal challenge with an R5 SHIV isolate J. Med. Primatol. 34 5-6 2005 226 236
52. L.J. Patterson, B. Peng, A.G. Abimiku, K. Aldrich, L. Murty, P.D. Markham, V.S. Kalyanaraman, W.G. Alvord, J. Tartaglia, G. Franchini, and M. Robert-Guroff Cross-protection in NYVAC-HIV-1-immunized/HIV-2-challenged but not in NYVAC-HIV-2-immunized/SHIV-challenged rhesus macaques AIDS 14 16 2000 2445 2455
53. L.J. Patterson, N. Malkevitch, D. Venzon, J. Pinczewski, V.R. Gomez-Roman, L. Wang, V.S. Kalyanaraman, P.D. Markham, F.A. Robey, and M. Robert-Guroff Protection against mucosal simian immunodeficiency virus SIV (mac251) challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boosting J. Virol. 78 5 2004 2212 2221
54. S. Perri, C.E. Greer, K. Thudium, B. Doe, H. Legg, H. Liu, R.E. Romero, Z. Tang, Q. Bin, T.W. Dubensky Jr., M. Vajdy, G.R. Otten, and J.M. Polo An alphavirus replicon particle chimera derived from Venezuelan equine encephalitis and sindbis viruses is a potent gene-based vaccine delivery vector J. Virol. 77 19 2003 10394 10403
55. A. Radaelli, J. Nacsa, W.P. Tsai, Y. Edghill-Smith, C. Zanotto, V. Elli, D. Venzon, E. Tryniszewska, P. Markham, G.P. Mazzara, D. Panicali, C. De Giuli Morghen, and G. Franchini Prior DNA immunization enhances immune response to dominant and subdominant viral epitopes induced by a fowlpox-based SIVmac vaccine in long-term slow-progressor macaques infected with SIVmac251 Virology 312 1 2003 181 195
56. E. Ramsburg, N.F. Rose, P.A. Marx, M. Mefford, D.F. Nixon, W.J. Moretto, D. Montefiori, P. Earl, B. Moss, and J.K. Rose Highly effective control of an AIDS virus challenge in macaques by using vesicular stomatitis virus and modified vaccinia virus Ankara vaccine vectors in a single-boost protocol J. Virol. 78 8 2004 3930 3940
57. M. Rao, G.R. Matyas, T.C. Vancott, D.L. Birx, and C.R. Alving Immunostimulatory CpG motifs induce CTL responses to HIV type I oligomeric gp140 envelope protein Immunol. Cell Biol. 82 5 2004 523 530
58. R.A. Rasmussen, R. Hofmann-Lehman, D.C. Montefiori, P.L. Li, V. Liska, J. Vlasak, T.W. Baba, J.E. Schmitz, M.J. Kuroda, H.L. Robinson, H.M. McClure, S. Lu, S.L. Hu, T.A. Rizvi, and R.M. Ruprecht DNA prime/protein boost vaccine strategy in neonatal macaques against simian human immunodeficiency virus J. Med. Primatol. 31 1 2002 40 60
59. A. Reyes-Sandoval, J.C. Fitzgerald, R. Grant, S. Roy, Z.Q. Xiang, Y. Li, G.P. Gao, J.M. Wilson, and H.C. Ertl Human immunodeficiency virus type 1-specific immune responses in primates upon sequential immunization with adenoviral vaccine carriers of human and simian serotypes J. Virol. 78 14 2004 7392 7399
60. J.F. Richmond, S. Lu, J.C. Santoro, J. Weng, S.L. Hu, D.C. Montefiori, and H.L. Robinson Studies of the neutralizing activity and avidity of anti-human immunodeficiency virus type 1 Env antibody elicited by DNA priming and protein boosting J. Virol. 72 11 1998 9092 9100
61. S. Santra, D.H. Barouch, B. Korioth-Schmitz, C.I. Lord, G.R. Krivulka, F. Yu, M.H. Beddall, D.A. Gorgone, M.A. Lifton, A. Miura, V. Philippon, K. Manson, P.D. Markham, J. Parrish, M.J. Kuroda, J.E. Schmitz, R.S. Gelman, J.W. Shiver, D.C. Montefiori, D. Panicali, and N.L. Letvin Recombinant poxvirus boosting of DNA-primed rhesus monkeys augments peak but not memory T lymphocyte responses Proc. Natl. Acad. Sci. U.S.A. 101 30 2004 11088 11093
62. S. Sasaki, K. Sumino, K. Hamajima, J. Fukushima, N. Ishii, S. Kawamoto, H. Mohri, C.R. Kensil, and K. Okuda Induction of systemic and mucosal immune responses to human immunodeficiency virus type 1 by a DNA vaccine formulated with QS-21 saponin adjuvant via intramuscular and intranasal routes J. Virol. 72 6 1998 4931 4939
63. M.S. Seaman, S. Santra, M.H. Newberg, V. Philippon, K. Manson, L. Xu, R.S. Gelman, D. Panicali, J.R. Mascola, G.J. Nabel, and N.L. Letvin Vaccine-elicited memory cytotoxic T lymphocytes contribute to Mamu-A*01-associated control of simian/human immunodeficiency virus 89.6P replication in rhesus monkeys J. Virol. 79 8 2005 4580 4588
64. M.S. Seaman, L. Xu, K. Beaudry, K.L. Martin, M.H. Beddall, A. Miura, A. Sambor, B.K. Chakrabarti, Y. Huang, R. Bailer, R.A. Koup, J.R. Mascola, G.J. Nabel, and N.L. Letvin Multiclade human immunodeficiency virus type 1 envelope immunogens elicit broad cellular and humoral immunity in rhesus monkeys J. Virol. 79 5 2005 2956 2963
65. S.A. Shelburne, F. Visnegarwala, J. Darcourt, E.A. Graviss, T.P. Giordano, A.C. White Jr., and R.J. Hamill Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy AIDS 19 4 2005 399 406
66. J.M. Smith, R.R. Amara, H.M. McClure, M. Patel, S. Sharma, H. Yi, L. Chennareddi, J.G. Herndon, S.T. Butera, W. Heneine, D.L. Ellenberger, B. Parekh, P.L. Earl, L.S. Wyatt, B. Moss, and H.L. Robinson Multiprotein HIV type 1 clade B DNA/MVA vaccine: construction, safety, and immunogenicity in Macaques AIDS Res. Hum. Retrovir. 20 6 2004 654 665
67. P.M. Smooker, K.R. Steeper, D.R. Drew, R.A. Strugnell, and T.W. Spithill Humoral responses in mice following vaccination with DNA encoding glutathione S-transferase of Fasciola hepatica: effects of mode of vaccination and the cellular compartment of antigen expression Parasite Immunol. 21 7 1999 357 364
68. H. Soudeyns, S. Paolucci, C. Chappey, M.B. Daucher, C. Graziosi, M. Vaccarezza, O.J. Cohen, A.S. Fauci, and G. Pantaleo Selective pressure exerted by immunodominant HIV-1-specific cytotoxic T lymphocyte responses during primary infection drives genetic variation restricted to the cognate epitope Eur. J. Immunol. 29 11 1999 3629 3635
69. S.M. Sumida, D.M. Truitt, M.G. Kishko, J.C. Arthur, S.S. Jackson, D.A. Gorgone, M.A. Lifton, W. Koudstaal, M.G. Pau, S. Kostense, M.J. Havenga, J. Goudsmit, N.L. Letvin, and D.H. Barouch Neutralizing antibodies and CD8+ T lymphocytes both contribute to immunity to adenovirus serotype 5 vaccine vectors J. Virol. 78 6 2004 2666 2673
70. J.C. Sun, M.A. Williams, and M.J. Bevan CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection Nat. Immunol. 5 9 2004 927 933
71. N. Teleshova, J. Kenney, J. Jones, J. Marshall, G. Van Nest, J. Dufour, R. Bohm, J.D. Lifson, A. Gettie, and M. Pope CpG-C immunostimulatory oligodeoxyribonucleotide activation of plasmacytoid dendritic cells in rhesus macaques to augment the activation of IFN-gamma-secreting simian immunodeficiency virus-specific T cells J. Immunol. 173 3 2004 1647 1657
72. S. van Drunen Littel-van den Hurk, R.P. Braun, B.C. Karvonen, T. King, D. Yoo, and L.A. Babiuk Immune responses and protection induced by DNA vaccines encoding bovine parainfluenza virus type 3 glycoproteins Virology 260 1 1999 35 46
73. R. Wagner, Y. Shao, and H. Wolf Correlates of protection, antigen delivery and molecular epidemiology: basics for designing an HIV vaccine Vaccine 17 13-14 1999 1706 1710
74. D.C. Waite, E.W. Jacobson, F.A. Ennis, R. Edelman, B. White, R. Kammer, C. Anderson, and C.R. Kensil Three double-blind, randomized trials evaluating the safety and tolerance of different formulations of the saponin adjuvant QS-21 Vaccine 19 28-29 2001 3957 3967
75. Q.M. Wang, S.H. Sun, Z.L. Hu, M. Yin, C.J. Xiao, and J.C. Zhang Improved immunogenicity of a tuberculosis DNA vaccine encoding ESAT6 by DNA priming and protein boosting Vaccine 22 27-28 2004 3622 3627
76. R.L. Willey, R. Byrum, M. Piatak, Y.B. Kim, M.W. Cho, J.L. Rossio Jr., J. Bess Jr., T. Igarashi, Y. Endo, L.O. Arthur, J.D. Lifson, and M.A. Martin Control of viremia and prevention of simian-human immunodeficiency virus-induced disease in rhesus macaques immunized with recombinant vaccinia viruses plus inactivated simian immunodeficiency virus and human immunodeficiency virus type 1 particles J. Virol. 77 2 2003 1163 1174
77. F.W. Wit, R. van Leeuwen, G.J. Weverling, S. Jurriaans, K. Nauta, R. Steingrover, J. Schuijtemaker, X. Eyssen, D. Fortuin, M. Weeda, F. de Wolf, P. Reiss, S.A. Danner, and J.M. Lange Outcome and predictors of failure of highly active antiretroviral therapy: one-year follow-up of a cohort of human immunodeficiency virus type 1-infected persons J. Infect. Dis. 179 4 1999 790 798
78. C.P. Wong, C.Y. Okada, and R. Levy TCR vaccines against T cell lymphoma: QS-21 and IL-12 adjuvants induce a protective CD8+ T cell response J. Immunol. 162 4 1999 2251 2258
79. S.B. Wong, C.B. Buck, X. Shen, and R.F. Siliciano An evaluation of enforced rapid proteasomal degradation as a means of enhancing vaccine-induced CTL responses J. Immunol. 173 5 2004 3073 3083
80. T. Woodberry, J. Gardner, S.L. Elliott, S. Leyrer, D.M. Purdie, P. Chaplin, and A. Suhrbier Prime boost vaccination strategies: CD8 T cell numbers, protection, and Th1 bias J. Immunol. 170 5 2003 2599 2604
81. I. Yoshizawa, Y. Soda, T. Mizuochi, S. Yasuda, T.A. Rizvi, T. Takemori, and Y. Tsunetsugu-Yokota Enhancement of mucosal immune response against HIV-1 Gag by DNA immunization Vaccine 19 20-22 2001 2995 3003
82. X.G. Yu, M.M. Addo, E.S. Rosenberg, W.R. Rodriguez, P.K. Lee, C.A. Fitzpatrick, M.N. Johnston, D. Strick, P.J. Goulder, B.D. Walker, and M. Altfeld Consistent patterns in the development and immunodominance of human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T-cell responses following acute HIV-1 infection J. Virol. 76 17 2002 8690 8701